Covovax trials begin in India, hope to launch it by Sept 2021: Adar Poonawalla
PTI, Mar 27, 2021, 2:49 PM IST
New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said clinical trials of COVID-19 vaccine Covovax have begun in India and the company hopes to launch it by September this year.
In August 2020, American vaccine company Novavax, Inc had announced a licence agreement with SII for the development and commercialization of NVX-CoV2373, its COVID-19 vaccine candidate, in low and middle-income countries and India.
“Covovax trials finally begin in India; the vaccine is made through a partnership with @Novavax and @SerumInstIndia. It has been tested against African and UK variants of #COVID19 and has an overall efficacy of 89%. Hope to launch by September 2021!,” Poonawalla said in a tweet.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Elon Musk says India visit delayed due to Tesla obligations
Scindia, Chouhan, Digvijaya among 144 candidates in fray for 3rd phase of LS polls in MP
Woman assaulted in Kerala for rejecting marriage proposal
Three involved in shooting near polling station in Manipur arrested
Indian sentenced for five years for selling controlled substance on dark web
MUST WATCH
Latest Additions
Elon Musk says India visit delayed due to Tesla obligations
Udupi Sri Krishna Matha: Sundarakanda Pravachana inaugurated
Scindia, Chouhan, Digvijaya among 144 candidates in fray for 3rd phase of LS polls in MP
Dhoni simply owns that space, says Fleming
Woman assaulted in Kerala for rejecting marriage proposal